Literature DB >> 26137255

miR-615-3p expression level in bone marrow is associated with tumor recurrence in hepatocellular carcinoma.

Ryota Mukai1, Yoshito Tomimaru1, Hiroaki Nagano1, Hidetoshi Eguchi1, Koshi Mimori2, Akira Tomokuni1, Tadafumi Asaoka1, Hiroshi Wada1, Koichi Kawamoto1, Shigeru Marubashi1, Yuichiro Doki1, Masaki Mori1.   

Abstract

The significance of disseminated tumor cells (DTCs) in bone marrow (BM) on tumor recurrence has not been investigated in patients with hepatocellular carcinoma (HCC). The aim of te present study was to clarify the molecular characteristics of DTCs that affect postoperative recurrence based on microRNA (miRNA) expression profiles in clinical HCC patients undergoing curative resection. DTCs were prospectively collected from the BM of preoperative HCC patients using immunomagnetic beads and subjected to miRNA microarray analysis. Microarray analysis of nine HCC patients (n=5 patients with postoperative HCC recurrence, n=4 patients without HCC recurrence) demonstrated that miR-615-3p is significantly upregulated in the DTCs of patients with recurrence compared to the DTCs from patients without recurrence. In vitro experiments demonstrated that the miR-615-3p expression level is significantly correlated with malignant characteristics in HCC cells. These data suggest that miR-615-3p in DTCs may play an important role in postoperative HCC recurrence, which suggests that miR-615-3p is a potential target molecule for regulating postoperative HCC recurrence.

Entities:  

Keywords:  bone marrow; disseminated tumor cells; hepatocellular carcinoma; miR-615-3p; microRNA

Year:  2015        PMID: 26137255      PMCID: PMC4471528          DOI: 10.3892/mco.2015.514

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  38 in total

1.  A high-throughput method to monitor the expression of microRNA precursors.

Authors:  Thomas D Schmittgen; Jinmai Jiang; Qian Liu; Liuqing Yang
Journal:  Nucleic Acids Res       Date:  2004-02-25       Impact factor: 16.971

Review 2.  Micrometastatic disease in breast cancer: clinical implications.

Authors:  Michail Ignatiadis; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  Eur J Cancer       Date:  2008-12       Impact factor: 9.162

Review 3.  Hepatocellular carcinoma--epidemiological trends and risk factors.

Authors:  Kerstin Schütte; Jan Bornschein; Peter Malfertheiner
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.

Authors:  Akira Tomokuni; Hidetoshi Eguchi; Yoshito Tomimaru; Hiroshi Wada; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masahiro Tanemura; Hiroaki Nagano; Masaki Mori; Yuichiro Doki
Journal:  Biochem Biophys Res Commun       Date:  2011-10-01       Impact factor: 3.575

6.  Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

Authors:  Cristina Raimondi; Angela Gradilone; Giuseppe Naso; Bruno Vincenzi; Arianna Petracca; Chiara Nicolazzo; Antonella Palazzo; Rosa Saltarelli; Franco Spremberg; Enrico Cortesi; Paola Gazzaniga
Journal:  Breast Cancer Res Treat       Date:  2011-02-05       Impact factor: 4.872

7.  Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves.

Authors:  M Sakon; K Umeshita; H Nagano; H Eguchi; S Kishimoto; A Miyamoto; S Ohshima; K Dono; S Nakamori; M Gotoh; M Monden
Journal:  Arch Surg       Date:  2000-12

8.  Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.

Authors:  H Eguchi; H Nagano; H Yamamoto; A Miyamoto; M Kondo; K Dono; S Nakamori; K Umeshita; M Sakon; M Monden
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

9.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

10.  Bone marrow micrometastasis detected by RT-PCR in esophageal squamous cell carcinoma.

Authors:  Shoji Natsugoe; Saburo Nakashima; Akihiro Nakajo; Masataka Matsumoto; Hiroshi Okumura; Koki Tokuda; Futoshi Miyazono; Fumio Kijima; Kuniaki Aridome; Sumiya Ishigami; Sonshin Takao; Takashi Aikou
Journal:  Oncol Rep       Date:  2003 Nov-Dec       Impact factor: 3.906

View more
  9 in total

1.  Microarray-based Analysis of Genes, Transcription Factors, and Epigenetic Modifications in Lung Cancer Exposed to Nitric Oxide.

Authors:  Arnatchai Maiuthed; Ornjira Prakhongcheep; Pithi Chanvorachote
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 2.  Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives.

Authors:  Zhao Huang; Jingyuan Wen; Yufei Wang; Shenqi Han; Zhen Li; Xuemei Hu; Dongling Zhu; Zhenxiong Wang; Junnan Liang; Huifang Liang; Xiao-Ping Chen; Bixiang Zhang
Journal:  Front Med       Date:  2022-07-19       Impact factor: 9.927

3.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20

4.  Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.

Authors:  Medi Kori; Kazim Yalcin Arga
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 5.  miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair.

Authors:  Marisol Godínez-Rubí; Daniel Ortuño-Sahagún
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

6.  miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.

Authors:  Elena A Pudova; George S Krasnov; Kirill M Nyushko; Anastasiya A Kobelyatskaya; Maria V Savvateeva; Andrey A Poloznikov; Daniyar R Dolotkazin; Kseniya M Klimina; Zulfiya G Guvatova; Sergey A Simanovsky; Nataliya S Gladysh; Artemy T Tokarev; Nataliya V Melnikova; Alexey A Dmitriev; Boris Y Alekseev; Andrey D Kaprin; Marina V Kiseleva; Anastasiya V Snezhkina; Anna V Kudryavtseva
Journal:  BMC Med Genomics       Date:  2020-09-18       Impact factor: 3.063

7.  MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2.

Authors:  Jiangtao Liu; Yanli Jia; Lijuan Jia; Tingting Li; Lei Yang; Gongwen Zhang
Journal:  Oncol Res       Date:  2018-03-21       Impact factor: 5.574

Review 8.  microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins.

Authors:  Abu Musa Md Talimur Reza; Yu-Guo Yuan
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

9.  miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach.

Authors:  Jovito Cesar Santos-Álvarez; Juan Manuel Velázquez-Enríquez; Rosendo García-Carrillo; César Rodríguez-Beas; Alma Aurora Ramírez-Hernández; Edilburga Reyes-Jiménez; Karina González-García; Armando López-Martínez; Laura Pérez-Campos Mayoral; Sergio Roberto Aguilar-Ruiz; María de Los Ángeles Romero-Tlalolini; Honorio Torres-Aguilar; Luis Castro-Sánchez; Jaime Arellanes-Robledo; Verónica Rocío Vásquez-Garzón; Rafael Baltiérrez-Hoyos
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.